Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of a Bilberry Extract Standardised to a Content of 25% Anthocyanosides in Improving the Night Vision of Healthy Volunteers: a Double-blind, Randomized, Placebo Controlled, Cross-over Trial Over 2 x 28 Days

NCT02194361 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT02194361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02194361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of a Bilberry Extract Standardised to a Content of 25% Anthocyanosides in Improving the Night Vision of Healthy Volunteers: a Double-blind, Randomized, Placebo Controlled, Cross-over Trial Over 2 x 28 Days
Lead sponsor
Boehringer Ingelheim
Phase
Phase 2
Overall status
Completed
Start date
December 31, 1999
Completion date
Not reported
Enrollment
119 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy